Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 4:00 pm Purchase | 13G | Bolt Biotherapeutics Inc. BOLT | TANG CAPITAL PARTNERS LP | 3,652,244 9.6% | 919,994 (+33.67%) | View |
2024-02-14 4:00 pm Purchase | 13G | CytomX Therapeutics Inc. CTMX | TANG CAPITAL PARTNERS LP | 6,550,000 9.8% | 3,039,555 (+86.59%) | View |
2024-02-14 4:00 pm Purchase | 13G | Elevation Oncology Inc. ELEV | TANG CAPITAL PARTNERS LP | 4,300,454 9.99% | 2,944,628 (+217.18%) | View |
2024-02-14 4:00 pm Sale | 13G | GENFIT S A ADS GNFT | TANG CAPITAL PARTNERS LP | 479,441 1% | -2,163,706 (-81.86%) | View |
2024-02-14 4:00 pm Purchase | 13G | KalVista Pharmaceuticals Inc. KALV | TANG CAPITAL PARTNERS LP | 3,440,345 9.96% | 243,899 (+7.63%) | View |
2024-02-14 4:00 pm Sale | 13G | MEI PHARMA INC PAR $ MEIP | TANG CAPITAL PARTNERS LP | 326,084 4.9% | -35,000 (-9.69%) | View |
2024-02-14 4:00 pm Sale | 13G | PYXIS ONCOLOGY INC PYXS | TANG CAPITAL PARTNERS LP | 0 0% | -3,470,700 (Position Closed) | View |
2024-02-14 4:00 pm Purchase | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPHW | TANG CAPITAL PARTNERS LP | 3,098,615 9.99% | 832,386 (+36.73%) | View |
2024-02-14 4:00 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | TANG CAPITAL PARTNERS LP | 2,204,797 6.7% | 203,212 (+10.15%) | View |
2024-02-14 4:00 pm Sale | 13G | THARIMMUNIE INC THAR | TANG CAPITAL PARTNERS LP | 0 0% | -252,549 (Position Closed) | View |
2024-02-05 4:49 pm Purchase | 13G | PRECISION BIOSCIENCES INC DTIL | TANG CAPITAL PARTNERS LP | 6,400,000 5.2% | 6,400,000 (New Position) | View |
2024-02-05 4:48 pm Purchase | 13G | LENZ Therapeutics Inc. LENZ | TANG CAPITAL PARTNERS LP | 3,117,843 5.4% | 3,117,843 (New Position) | View |
2024-02-02 4:00 pm Sale | 13D | Rain Oncology Inc. RAIN | TANG CAPITAL PARTNERS LP | 0 0% | -4,024,486 (Position Closed) | View |
2024-01-29 4:00 pm Purchase | 13G | Ventyx Biosciences Inc. VTYX | TANG CAPITAL PARTNERS LP | 3,100,000 5.2% | 3,100,000 (New Position) | View |
2024-01-26 4:28 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | TANG CAPITAL PARTNERS LP | 426,220 9.6% | 426,220 (New Position) | View |
2024-01-12 06:02 am Unchanged | 13D | Theseus Pharmaceuticals Inc. THRX | TANG CAPITAL PARTNERS LP | 3,255,026 7.3% | 0 (Unchanged) | View |
2024-01-02 4:00 pm Sale | 13G | ASLAN PHARMACEUTICALS LTD SPON ASLN | TANG CAPITAL PARTNERS LP | 6,134,975 1.5% | -39,020,205 (-86.41%) | View |
2023-12-28 06:00 am Purchase | 13D | Theseus Pharmaceuticals Inc. THRX | TANG CAPITAL PARTNERS LP | 3,255,026 7.3% | 153,420 (+4.95%) | View |
2023-12-26 5:00 pm Purchase | 13D | Reneo Pharmaceuticals Inc. RPHM | TANG CAPITAL PARTNERS LP | 3,330,000 9.996% | 3,330,000 (New Position) | View |
2023-12-07 4:00 pm Purchase | 13G | THARIMMUNIE INC THAR | TANG CAPITAL PARTNERS LP | 252,549 9.99% | 252,549 (New Position) | View |